Marc Rivière

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Marc Rivière is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Rivière has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Rivière's work include Helicobacter pylori-related gastroenterology studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Marc Rivière is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Marc Rivière collaborates with scholars based in Canada, United States and France. Marc Rivière's co-authors include Peter Malfertheiner, Françis Mégraud, Monique Giguère, Jean‐Charles Delchier, Franco Bazzoli, Theodore L. Munsat, Barbara Law, Lee Ford-Jones, Christophe Renou and Vlad Ratziu and has published in prestigious journals such as The Lancet, Gastroenterology and PEDIATRICS.

In The Last Decade

Marc Rivière

14 papers receiving 1.1k citations

Hit Papers

Helicobacter pylori eradication with a capsule containing... 2011 2026 2016 2021 2011 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
    2011 379 citations Peter Malfertheiner, Franco Bazzoli et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Rivière Canada 10 421 386 190 159 149 15 1.1k
Susan E. Johnson United States 21 251 0.6× 269 0.7× 301 1.6× 53 0.3× 15 0.1× 49 1.4k
Linda Wittkop France 19 215 0.5× 331 0.9× 81 0.4× 47 0.3× 37 0.2× 80 1.2k
Christian Felley Switzerland 25 1.1k 2.5× 689 1.8× 192 1.0× 255 1.6× 15 0.1× 71 2.1k
Lúcia Libanez Bessa Campelo Braga Brazil 21 622 1.5× 110 0.3× 147 0.8× 170 1.1× 32 0.2× 44 962
Stanley Levin Israel 22 151 0.4× 385 1.0× 116 0.6× 86 0.5× 50 0.3× 101 1.8k
Rebecca Thomas United States 24 547 1.3× 540 1.4× 248 1.3× 370 2.3× 289 1.9× 67 1.8k
Jayleen Grams United States 25 594 1.4× 334 0.9× 133 0.7× 65 0.4× 28 0.2× 49 1.5k
J. H. Wandall Denmark 15 189 0.4× 239 0.6× 66 0.3× 83 0.5× 44 0.3× 32 782
P.-H. Chyou United States 20 1.7k 4.0× 225 0.6× 599 3.2× 296 1.9× 12 0.1× 28 2.7k
Ming‐Jong Bair Taiwan 20 509 1.2× 242 0.6× 167 0.9× 199 1.3× 4 0.0× 95 982

Countries citing papers authored by Marc Rivière

Since Specialization
Citations

This map shows the geographic impact of Marc Rivière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rivière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rivière more than expected).

Fields of papers citing papers by Marc Rivière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Rivière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rivière. The network helps show where Marc Rivière may publish in the future.

Co-authorship network of co-authors of Marc Rivière

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Rivière. A scholar is included among the top collaborators of Marc Rivière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Rivière. Marc Rivière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Malfertheiner, Peter, Franco Bazzoli, Jean‐Charles Delchier, et al.. (2011). Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. The Lancet. 377(9769). 905–913. 379 indexed citations breakdown →
2.
3.
Ratziu, Vlad, Victor de Lédinghen, F. Oberti, et al.. (2010). A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. Journal of Hepatology. 54(5). 1011–1019. 257 indexed citations
4.
5.
Bitzan, Martin, et al.. (2009). Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 53(7). 3081–3087. 64 indexed citations
6.
Kearney, Paul, Nathan Currier, Daniel Chelsky, et al.. (2008). Global Proteomics: Pharmacodynamic Decision Making via Geometric Interpretations of Proteomic Analyses. Journal of Proteomics & Bioinformatics. 1(7). 315–328. 7 indexed citations
7.
Peña, Carmen, et al.. (2006). Prevention of urinary tract infections in palliative radiation for vertebral metastasis and spinal compression: A pilot study in 71 patients. International Journal of Radiation Oncology*Biology*Physics. 64(3). 935–940. 13 indexed citations
8.
Voccia, Isabelle, et al.. (2004). 282: Mycobacterium Phlei Cell Wall Extract for the Treatment of Superficial Bladder Cancer: Final Results of a Phase 2 Trial. The Journal of Urology. 171(4S). 74–74. 2 indexed citations
9.
Law, Barbara, et al.. (1999). Cost of Chickenpox in Canada: Part II. Cost of Complicated Cases and Total Economic Impact. PEDIATRICS. 104(1). 7–14. 55 indexed citations
10.
Law, Barbara, Lee Ford-Jones, Noni MacDonald, et al.. (1999). Cost of Chickenpox in Canada: Part I. Cost of Uncomplicated Cases. PEDIATRICS. 104(1). 1–6. 143 indexed citations
11.
Rivière, Marc, et al.. (1998). An Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With Riluzole. Archives of Neurology. 55(4). 526–526. 149 indexed citations
12.
Rivière, Marc, et al.. (1998). Economic burden of amyotrophic lateral sclerosis in the United Kingdom. Journal of Medical Economics. 1(1-4). 235–245. 12 indexed citations
13.
Rivière, Marc, et al.. (1997). Economic Benefits of a Routine Second Dose of Combined Measles, Mumps and Rubella Vaccine in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology. 8(5). 257–264. 14 indexed citations
14.
Covens, Allan, et al.. (1996). Is paclitaxel and cisplatin a cost-effective first-line therapy for advanced ovarian carcinoma?. Cancer. 77(10). 2086–2091. 17 indexed citations
15.
Keown, Paul, et al.. (1995). Economic analysis of Sandimmune Neoral in Canada in stable renal transplant patients.. PubMed. 27(2). 1845–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan E. Johnson Breakdown of academic impact, for papers by Linda Wittkop Breakdown of academic impact, for papers by Christian Felley Breakdown of academic impact, for papers by Lúcia Libanez Bessa Campelo Braga Breakdown of academic impact, for papers by Stanley Levin Breakdown of academic impact, for papers by Rebecca Thomas Breakdown of academic impact, for papers by Jayleen Grams Breakdown of academic impact, for papers by J. H. Wandall Breakdown of academic impact, for papers by P.-H. Chyou Breakdown of academic impact, for papers by Ming‐Jong Bair
Rankless by CCL
2026